These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 29337259)
1. Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies. Shariatpanahi SP; Shariatpanahi SP; Madjidzadeh K; Hassan M; Abedi-Valugerdi M J Theor Biol; 2018 Apr; 442():1-10. PubMed ID: 29337259 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of low-dose fludarabine or 5-fluorouracil on the tumor growth and myeloid derived immunosuppression status of tumor-bearing mice. Abedi-Valugerdi M; Zheng W; Benkessou F; Zhao Y; Hassan M Int Immunopharmacol; 2017 Jun; 47():173-181. PubMed ID: 28411578 [TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice. Khosravianfar N; Hadjati J; Namdar A; Boghozian R; Hafezi M; Ashourpour M; Kheshtchin N; Banitalebi M; Mirzaei R; Razavi SA Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):47-55. PubMed ID: 29512369 [TBL] [Abstract][Full Text] [Related]
4. Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice. Abedi-Valugerdi M; Wolfsberger J; Pillai PR; Zheng W; Sadeghi B; Zhao Y; Hassan M Int Immunopharmacol; 2016 Nov; 40():41-49. PubMed ID: 27580414 [TBL] [Abstract][Full Text] [Related]
5. Immunogenic chemotherapy in two mouse colon cancer models. Taniura T; Iida Y; Kotani H; Ishitobi K; Tajima Y; Harada M Cancer Sci; 2020 Oct; 111(10):3527-3539. PubMed ID: 32816355 [TBL] [Abstract][Full Text] [Related]
6. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression. Bruno A; Mortara L; Baci D; Noonan DM; Albini A Front Immunol; 2019; 10():771. PubMed ID: 31057536 [TBL] [Abstract][Full Text] [Related]
7. Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in mice. Pilot T; Fratti A; Thinselin C; Perrichet A; Demontoux L; Limagne E; Derangère V; Ilie A; Ndiaye M; Jacquin E; Garrido C; Ghiringhelli F; Chalmin F; Rébé C J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32385145 [TBL] [Abstract][Full Text] [Related]
8. Prediction of anti-CD25 and 5-FU treatments efficacy for pancreatic cancer using a mathematical model. Shafiekhani S; Dehghanbanadaki H; Fatemi AS; Rahbar S; Hadjati J; Jafari AH BMC Cancer; 2021 Nov; 21(1):1226. PubMed ID: 34781899 [TBL] [Abstract][Full Text] [Related]
9. Supplementation of l-arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapy. Satoh Y; Kotani H; Iida Y; Taniura T; Notsu Y; Harada M Cancer Sci; 2020 Jul; 111(7):2248-2258. PubMed ID: 32426941 [TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin regulates myeloid-derived suppressor cell-mediated immunosuppression via downregulation of nuclear factor-κB signaling. Kim NR; Kim YJ Cancer Med; 2019 Jan; 8(1):276-288. PubMed ID: 30592157 [TBL] [Abstract][Full Text] [Related]
11. CD205 Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883 [TBL] [Abstract][Full Text] [Related]
12. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188 [TBL] [Abstract][Full Text] [Related]
13. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells. Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678 [TBL] [Abstract][Full Text] [Related]
14. Suppression of T cells by myeloid-derived suppressor cells in cancer. Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507 [TBL] [Abstract][Full Text] [Related]
15. Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation. Yang Y; Li C; Liu T; Dai X; Bazhin AV Front Immunol; 2020; 11():1371. PubMed ID: 32793192 [TBL] [Abstract][Full Text] [Related]
16. Mouse CD8 Li Z; Wu Y; Wang C; Zhang M Cancer Immunol Immunother; 2019 Aug; 68(8):1303-1315. PubMed ID: 31278476 [TBL] [Abstract][Full Text] [Related]
17. Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function. Stiff A; Trikha P; Mundy-Bosse B; McMichael E; Mace TA; Benner B; Kendra K; Campbell A; Gautam S; Abood D; Landi I; Hsu V; Duggan M; Wesolowski R; Old M; Howard JH; Yu L; Stasik N; Olencki T; Muthusamy N; Tridandapani S; Byrd JC; Caligiuri M; Carson WE Clin Cancer Res; 2018 Apr; 24(8):1891-1904. PubMed ID: 29363526 [No Abstract] [Full Text] [Related]
19. Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma. Orecchioni S; Talarico G; Labanca V; Calleri A; Mancuso P; Bertolini F Br J Cancer; 2018 May; 118(10):1329-1336. PubMed ID: 29695766 [TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells depletion may cause pregnancy loss via upregulating the cytotoxicity of decidual natural killer cells. Ren J; Zeng W; Tian F; Zhang S; Wu F; Qin X; Zhang Y; Lin Y Am J Reprod Immunol; 2019 Apr; 81(4):e13099. PubMed ID: 30737988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]